Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men: a novel demonstration
2008 StandoutNobel
Targeting the Metabolic Microenvironment of Tumors
2012
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Cancer treatment and survivorship statistics, 2022
2022 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Testicular cancer
2018
mTOR Signaling in Growth Control and Disease
2012 Standout
Akt and mTOR in B Cell Activation and Differentiation
2012
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
2011
Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance
2011
Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations
2011
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression
2006
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Rapamycin: One Drug, Many Effects
2014 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
mTOR signaling and drug development in cancer
2010
Telomere Attrition Due to Infection
2008
The biology and function of fibroblasts in cancer
2016 Standout
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
2018
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
Temsirolimus in the treatment of mantle cell lymphoma
2013
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapies
2013
Targeting apoptosis in cancer therapy
2020 Standout
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group
2010
Widespread Translational Remodeling during Human Neuronal Differentiation
2017 StandoutNobel
KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi’s sarcoma
2015 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Metabolic reprogramming in macrophage responses
2021
Association Between Telomere Length, Specific Causes of Death, and Years of Healthy Life in Health, Aging, and Body Composition, a Population-Based Cohort Study
2009 StandoutNobel
Targeting the translation machinery in cancer
2015
Molecular Karyotyping in Sarcoma Diagnostics and Research
2006
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
2018 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
The PI3K Pathway in Human Disease
2017 Standout
Current treatment strategies for inhibiting mTOR in cancer
2014
Rapamycin passes the torch: a new generation of mTOR inhibitors
2011
Novel disease targets and management approaches for diffuse large B-cell lymphoma
2010
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma
2011
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
2009 StandoutNobel
Molecular pathogenesis of mantle cell lymphoma
2012
On the significance of the heterogeneity in molecular size of human serum γA-globulins
1965
The structure of the heavy chain of immunoglobulin and its relevance to the nature of the antibody-combining site. The Second CIBA Medal Lecture
1967 StandoutNobel
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
Targeting the mTOR Signaling Network for Cancer Therapy
2009
Telomere length is paternally inherited and is associated with parental lifespan
2007 StandoutNobel
PHYLOGENETIC ORIGINS OF ANTIBODY STRUCTURE
1965 StandoutNobel
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
Structure and biological properties of immunoglobulins
1967 StandoutNobel
DISC ELECTROPHORESIS‐I BACKGROUND AND THEORY*
1964 Standout
Therapeutic Targeting of the Tumor Microenvironment
2021
Disc Electrophoresis Study of Serum Proteins from Patients with Multiple Myeloma and Macroglobulinemia
1963
Degenerative Aortic Valve Stenosis, but not Coronary Disease, Is Associated With Shorter Telomere Length in the Elderly
2006
Structure and evolution of immunoglobulins
1970 StandoutNobel
Structure and Biological Activity of Immunoglobulins
1964
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors
2011
Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
2010
PHYLOGENETIC ORIGINS OF ANTIBODY STRUCTURE
1968 StandoutNobel
Cancer treatment and survivorship statistics, 2016
2016 Standout
Disulphide Bridges of Immunoglobin G1 Heavy Chains
1967 StandoutNatureNobel
Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy
2013
Cancer treatment and survivorship statistics, 2019
2019 Standout
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
2018
Isolation and characterization of a hemagglutinin from Limulus polyphemus
1968 StandoutNobel
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
QUANTITATIVE VARIATIONS IN L CHAIN TYPES IN GUINEA PIG ANTIHAPTEN ANTIBODIES
1966 StandoutNobel
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
2018
EMT, CTCs and CSCs in tumor relapse and drug-resistance
2015
PRESENCE OF TWO TYPES OF L POLYPEPTIDE CHAINS IN GUINEA PIG 7S IMMUNOGLOBULINS
1966 StandoutNobel
Telomere length and heredity: Indications of paternal inheritance
2005
Cancer treatment and survivorship statistics, 2014
2014 Standout
Amino acid sequence of the Fc region of a human gamma G-immunoglobulin.
1968 StandoutNobel
Works of Anna Laurell being referenced
Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group
2011
Intratumor versus intertumor heterogeneity in gene expression profiles of soft‐tissue sarcomas
2005
Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma
2017
Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: First Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial
2016
Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
2009
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status
2005
Sera from Patients with Myeloma, Macroglobulinemia, and Related Conditions as Studied by Ultracentrifugation
1961
Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
2005
Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program
2009
Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer Group
2011
Role Of High-Dose Cytarabine and Total Body Irradiation Conditioning before Autologous Stem Cell Transplantation In Mantle Cell Lymphoma - A Comparison Of Nordic MCL2, HOVON 45, and European MCL Younger Trials
2013
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
2009